Q4 2017 Holdings
Filed 2018-02-14 | 17 holdings | $5.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cellectis(CLLS) | SPONDS ADR | 15117K103 | $2.9M | 100,000 | 49.8% |
| Adaptimmune(ADAPY) | SPONDS ADR | 00653A107 | $1.7M | 250,000 | 28.5% |
| Aurinia Pharma(AUPH) | Common | 05156V102 | $1.1M | 252,129 | 19.5% |
| Crispr(CRSP) | NAMEN AKT | H17182108 | $45.8K | 1,951,359 | 0.8% |
| Sientra | Common | 82621J105 | $30.9K | 2,199,012 | 0.5% |
| Paratek | Common | 699374302 | $18.6K | 1,041,131 | 0.3% |
| Cymabay(CBAYUSD) | Common | 23257D103 | $10.6K | 1,147,077 | 0.2% |
| Obseva | Common | H5861P103 | $4.3K | 440,000 | 0.1% |
| GTX | Common | 40052B207 | $4.3K | 339,174 | 0.1% |
| Proteon | Common | 74371L109 | $3.7K | 2,017,872 | 0.1% |
| Chiasma(CHMA) | Common | 16706W102 | $3.4K | 2,080,595 | 0.1% |
| Cascadian | Common | 14740B606 | $3.4K | 925,000 | 0.1% |
| Dermira(DERMEUR) | Common | 24983L104 | $1.9K | 70,000 | 0.0% |
| Histogenix | Common | 43358V109 | $1.8K | 888,889 | 0.0% |
| Ultragenyx(RARE) | Common | 90400D108 | $1.8K | 38,100 | 0.0% |
| Immune Design | Common | 45252L103 | $1.4K | 352,300 | 0.0% |
| Lombard Medical | Common | G55598109 | $399 | 3,473,452 | 0.0% |